BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23453062)

  • 1. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
    Wei W; Lv PP; Chen XM; Yue ZG; Fu Q; Liu SY; Yue H; Ma GH
    Biomaterials; 2013 May; 34(15):3912-23. PubMed ID: 23453062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
    Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
    Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binary-copolymer system base on low-density lipoprotein-coupled N-succinyl chitosan lipoic acid micelles for co-delivery MDR1 siRNA and paclitaxel, enhances antitumor effects via reducing drug.
    Yang SD; Zhu WJ; Zhu QL; Chen WL; Ren ZX; Li F; Yuan ZQ; Li JZ; Liu Y; Zhou XF; Liu C; Zhang XN
    J Biomed Mater Res B Appl Biomater; 2017 Jul; 105(5):1114-1125. PubMed ID: 27008163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin-conjugated pH-sensitive platform for effective delivery of porous palladium nanoparticles and paclitaxel in cancer treatment.
    Nguyen HT; Soe ZC; Yang KY; Phung CD; Nguyen LT; Jeong JH; Jin SG; Choi HG; Ku SK; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2019 Apr; 176():265-275. PubMed ID: 30623814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy of glutathione-responsive chitosan based nanoparticles through co-delivery of chemotherapeutics, genes, and immune agents.
    Zhang L; Li Q; Chen J; Tang C; Yin C
    Carbohydr Polym; 2021 Oct; 270():118384. PubMed ID: 34364626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
    Wang X; Yang C; Zhang Y; Zhen X; Wu W; Jiang X
    Biomaterials; 2014 Aug; 35(24):6439-53. PubMed ID: 24811257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer.
    Sadreddini S; Safaralizadeh R; Baradaran B; Aghebati-Maleki L; Hosseinpour-Feizi MA; Shanehbandi D; Jadidi-Niaragh F; Sadreddini S; Kafil HS; Younesi V; Yousefi M
    Immunol Lett; 2017 Jan; 181():79-86. PubMed ID: 27916629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.